Ampio to Start First Clinical Trial in COVID-19 Program
- Friday, June 19, 2020, 7:12
- Business
- Add a comment
ENGLEWOOD, Colo., June 19, 2020 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company”), is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the Company is…
About the Author
adminasapcorp has written 41785 stories on this site.